Serious adverse events reported in placebo randomised controlled trials of oral naltrexone: a systematic review and meta-analysis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1741-7015
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Serious adverse events reported in placebo randomised controlled trials of oral naltrexone: a systematic review and meta-analysis ; volume:17 ; number:1 ; day:15 ; month:1 ; year:2019 ; pages:1-13 ; date:12.2019
BMC medicine ; 17, Heft 1 (15.1.2019), 1-13, 12.2019
- Creator
-
Bolton, Monica
Hodkinson, Alex
Boda, Shivani
Mould, Alan
Panagioti, Maria
Rhodes, Sarah
Riste, Lisa
Marwijk, Harm van
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12916-018-1242-0
- URN
-
urn:nbn:de:101:1-2019030423473485540244
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:53 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Bolton, Monica
- Hodkinson, Alex
- Boda, Shivani
- Mould, Alan
- Panagioti, Maria
- Rhodes, Sarah
- Riste, Lisa
- Marwijk, Harm van
- SpringerLink (Online service)
Other Objects (12)
Postmarketing Surveillance of Full Spectrum Hemp Extract CBD Products: Reported Adverse Events and Serious Adverse Events
Modeling an IT Support for Handling Serious Adverse Events in Clinical Trials
Clinical Trials Facing “Serious Adverse Events” during the Ongoing COVID-19 Pandemic
“Serious Adverse Events” Faced by Clinical Trials: Impact of the COVID-19 Pandemic
Serious Cardiovascular Adverse Events Reported with Intravenous Sedatives: A Retrospective Analysis of the MedWatch Adverse Event Reporting System
Serious adverse events and fatal adverse events associated with nivolumab treatment in cancer patients : Nivolumab-related serious/fatal adverse events
How to Investigate a Serious Adverse Event Reported During a Clinical Trial for a COVID-19 Vaccine
Serious adverse events and compensation in registration trials: a review of data from a Japanese university hospital
Literature review of vaccine-related adverse events reported from HPV vaccination in randomized controlled trials
Adverse Event Reporting in Cancer Clinical Trials: Incorporating Patient-Reported Methods. A Systematic Scoping Review
Rapid overview of systematic reviews of nocebo effects reported by patients taking placebos in clinical trials
Nephrogenic systemic fibrosis: a serious late adverse reaction to gadodiamide
Postmarketing Surveillance of Full Spectrum Hemp Extract CBD Products: Reported Adverse Events and Serious Adverse Events
Modeling an IT Support for Handling Serious Adverse Events in Clinical Trials
Clinical Trials Facing “Serious Adverse Events” during the Ongoing COVID-19 Pandemic
“Serious Adverse Events” Faced by Clinical Trials: Impact of the COVID-19 Pandemic
Serious Cardiovascular Adverse Events Reported with Intravenous Sedatives: A Retrospective Analysis of the MedWatch Adverse Event Reporting System
Serious adverse events and fatal adverse events associated with nivolumab treatment in cancer patients : Nivolumab-related serious/fatal adverse events
How to Investigate a Serious Adverse Event Reported During a Clinical Trial for a COVID-19 Vaccine
Serious adverse events and compensation in registration trials: a review of data from a Japanese university hospital
Literature review of vaccine-related adverse events reported from HPV vaccination in randomized controlled trials
Adverse Event Reporting in Cancer Clinical Trials: Incorporating Patient-Reported Methods. A Systematic Scoping Review
Rapid overview of systematic reviews of nocebo effects reported by patients taking placebos in clinical trials
Nephrogenic systemic fibrosis: a serious late adverse reaction to gadodiamide
Postmarketing Surveillance of Full Spectrum Hemp Extract CBD Products: Reported Adverse Events and Serious Adverse Events
Modeling an IT Support for Handling Serious Adverse Events in Clinical Trials
Clinical Trials Facing “Serious Adverse Events” during the Ongoing COVID-19 Pandemic
“Serious Adverse Events” Faced by Clinical Trials: Impact of the COVID-19 Pandemic
Serious Cardiovascular Adverse Events Reported with Intravenous Sedatives: A Retrospective Analysis of the MedWatch Adverse Event Reporting System
Serious adverse events and fatal adverse events associated with nivolumab treatment in cancer patients : Nivolumab-related serious/fatal adverse events
How to Investigate a Serious Adverse Event Reported During a Clinical Trial for a COVID-19 Vaccine
Serious adverse events and compensation in registration trials: a review of data from a Japanese university hospital
Literature review of vaccine-related adverse events reported from HPV vaccination in randomized controlled trials
Adverse Event Reporting in Cancer Clinical Trials: Incorporating Patient-Reported Methods. A Systematic Scoping Review
Rapid overview of systematic reviews of nocebo effects reported by patients taking placebos in clinical trials